🟢 Insulet is trading 4.7% up today as healthcare gains 1.59%

Insulet is trading 4.7% up at $146.34, outperforming a broadly weaker market as healthcare gains 1.59% during the regular session.

• No new positive company-specific catalyst was identified on August 18, 2026; recent coverage focuses on reduced 2026 sales-growth guidance and weaker U.S. Omnipod demand.
• The move is best characterized as sector-led defensive rotation as investors favor healthcare while technology and major indexes decline; confidence is medium.